share_log

Cyclacel Pharmaceuticals Inc | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(8.0%),Altium Growth Fund, LP EIN:(8.0%), etc.

Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G:超過5%持股股東披露文件-Altium Capital Management, LP EIN:(8.0%),Altium Growth Fund, LP EIN:(8.0%)等

美股SEC公告 ·  01/10 00:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息